Abstract
Antisocial and aggressive behaviors show considerable heritability and are central to disruptive behavior disorders (DBDs), but are also frequently observed in attention deficit hyperactivity disorder (ADHD). While the amygdala is implicated as a key neural structure, it remains unclear whether common genetic variants underlie this brain-behavior association. We hypothesized that polygenic (risk) scores for antisocial and aggressive behaviors (ASB-PRS) would be related to amygdala morphology. Using the Broad Antisocial Behavior Consortium genome-wide association study (GWAS; mostly population based cohorts), we calculated ASB-PRS in the NeuroIMAGE I ADHD case-control sample with varying levels of DBD symptomatology (n=679 from 379 families, aged 7 - 29). We first investigated associations of several ASB-PRS p value thresholds with the presence of DBD symptoms and self-reported antisocial behavior (ASB) to determine the threshold for further analyses. This PRS was then related to amygdala volume and shape using regression and vertex-wise analyses. Our results showed associations of ASB-PRS with the presence of DBD symptoms, self-reported ASB, and left basolateral amygdala shape, independent of ADHD symptom severity and ADHD-PRS, with a relative outward displacement of the vertices. No associations of ASB-PRS, DBD symptoms or self-reported ASB with amygdala volume were found. Our results indicate that genetic risk for antisocial and aggressive behaviors is related to amygdala shape alterations, and point to genetic sharing across different DBD and ASB and aggression-related phenotypes as a spectrum of genetically related quantitative traits. Additionally, our findings support the utility of vertex-based shape analyses in genetic studies of ASB, aggression, and DBDs.
Original language | English |
---|---|
Pages (from-to) | 63-73 |
Number of pages | 11 |
Journal | European Neuropsychopharmacology |
Volume | 62 |
Early online date | 30 Jul 2022 |
DOIs | |
Publication status | Published - Sept 2022 |
Bibliographical note
Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.Funding
This work is supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 603016 (MATRICS) and no. 602805 (Aggressotype) and by the European Community's Horizon 2020 Programme (H2020/2014 \u2013 2020) under grant agreements n\u00B0 667302 (CoCA), and n\u00B0 728018 (Eat2beNICE). The NeuroIMAGE- project was supported by NIH Grant R01MH62873, NWO Large Investment Grant 1750102007010 and ZonMW Grant 60- 60600-97-193, and grants from Radboud University Nijmegen Medical Center, University Medical Center Groningen and Accare, and VU University Amsterdam. J. Naaijen is supported by an NWO Veni grant (VI.Veni.194.032). B. Franke is supported by funding for the Dutch National Science Agenda NeurolabNL project (grant 400-17-602). None of the funding sources had a further role in study design; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication. We are very grateful to all families who participated in the NeuroIMAGE-study, and the whole NeuroIMAGE-team, including interviewers, technicians, scientists, clinicians, volunteers, and managers of all involved organizations and facilities, for recruitment and collection, and preprocessing of the data used in this study. This work is supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 603016 (MATRICS) and no. 602805 (Aggressotype) and by the European Community's Horizon 2020 Programme (H2020/2014 \u2013 2020) under grant agreements n\u00B0 667302 (CoCA), and n\u00B0 728018 (Eat2beNICE). The NeuroIMAGE- project was supported by NIH Grant R01MH62873, NWO Large Investment Grant 1750102007010 and ZonMW Grant 60- 60600-97-193, and grants from Radboud University Nijmegen Medical Center, University Medical Center Groningen and Accare, and VU University Amsterdam. J. Naaijen is supported by an NWO Veni grant (VI.Veni.194.032). B. Franke is supported by funding for the Dutch National Science Agenda NeurolabNL project (grant 400-17-602). None of the funding sources had a further role in study design; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication.
Funders | Funder number |
---|---|
Dutch National Science Agenda NeurolabNL | 400-17-602 |
European Community's Horizon 2020 Programme | 667302 |
National Institutes of Health | R01MH62873 |
National Institutes of Health | |
Chiropractic and Osteopathic College of Australasia | 728018 |
Chiropractic and Osteopathic College of Australasia | |
Seventh Framework Programme | 602805, 603016 |
Seventh Framework Programme | |
ZonMw | 60- 60600-97-193 |
ZonMw | |
Vrije Universiteit Amsterdam | VI.Veni.194.032 |
Vrije Universiteit Amsterdam | |
Nederlandse Organisatie voor Wetenschappelijk Onderzoek | 1750102007010 |
Nederlandse Organisatie voor Wetenschappelijk Onderzoek | |
Seventh Framework Programme | |
Radboud Universitair Medisch Centrum |